This article reviews specific clinical and research issues of herpes zoster related to geriatric medicine. Salient epidemiological and clinical issues include the increasing probability of zoster and postherpetic neuralgia with aging, age-related decline in immunity to varicella-zoster virus, the functional and psychosocial impact of zoster on the quality of life of the elderly, illness behavior in elderly patients with zoster, and varicella-zoster virus transmission and control in the nursing home. The role of antiviral therapy, corticosteroids, and analgesics; the measurement and analysis of pain, health-related quality of life, and functional status; and development of the varicella vaccine in the management of zoster in the elderly are also emphasized. Fertile research opportunities exist within these areas for investigators interested in infectious diseases, geriatrics, and other zoster-related disciplines.
Herpes zoster afflicts up to 600,000 persons in the United back in the T5 dermatome and told him he had shingles. The emergency department physician confirmed the diagnosis, States each year and causes substantial suffering among elderly individuals [1] . Increasingly large numbers of persons are expetreated him with meperidine, and sent him home with codeine and acyclovir. The rash healed over the next 3 weeks, but he riencing the disease, owing to population aging and increasing numbers of immunosuppressed hosts. The purpose of this prenoticed minimal relief from the acute pain. The patient has experienced severe postherpetic neuralgia sentation is to review specific issues of herpes zoster related to (PHN) for 5 years now and seeks relief. He describes a constant geriatrics and to emphasize potentially fruitful areas of research deep aching that is punctuated by sharp pains and involuntary collaboration between infectious diseases specialists and geriamuscle contractions in the area of the affected dermatome. In tricians. The review will begin with a description of the presenaddition, he complains bitterly about extremely sensitive skin tation of a patient seen in the Duke Geriatric Evaluation and in the affected dermatome and is unable to wear clothes over Treatment Clinic 5 years after the onset of zoster. the area. Over the years, he has tried codeine, oxycodone, morphine, amitriptyline, amitriptyline-perphenazine, topical liPatient Presentation docaine, capsaicin, mexiletine, phenytoin, carbamazepine, nonsteroidal antiinflammatory agents, cyclobenzaprine, transcutaThe patient, a 70-year-old man, was in excellent health until neous electrical nerve stimulation, acupuncture, epidural the acute onset of a ''terrible'' pain in his right upper abdomen anesthetic/steroid injections, and intercostal nerve blocks, all and lower chest. The pain was initially diagnosed as cholecystiwithout relief. tis, but diagnostic testing revealed no gallstones. The cause of Two years after the onset of rash, while taking mexiletine and the pain remained elusive until 4 days after onset of rash, when amitriptyline, he developed ''grogginess'' and poor balance, he visited the emergency department because of ongoing pain.
resulting in a subsequent fall and hip fracture, necessitating a While helping him remove his shirt for the examination, a total hip replacement. His PHN interferes with dressing, bathnurse pointed out a red, blistering rash located on his right ing, grooming, traveling, ability to concentrate, and sleeping. He and his wife go out of the house on social occasions very infrequently. He was still working as an automobile mechanic the illness was characterized by a confusing prodrome and many patients experience disabling allodynia, or pain brought immunology since these studies were published. The immunology of zoster and aging is a rich area for further investigation. on by an innocuous stimulus, in the affected dermatome. Unfortunately, a subset of PHN patients not only do not respond to Another important area of development is clinical and molecular epidemiologic studies of risk factors for zoster. For examtreatment but also suffer from adverse drug effects, a major problem in geriatric medicine.
ple, we determined if there were racial differences in the lifetime occurrence and incidence of herpes zoster in the Duke The physical, psychosocial, and functional impact of acute and chronic zoster pain in the elderly -the fatigue, insomnia, Established Populations for Epidemiologic Studies of the Elderly, a probability sample of community-dwelling persons depression, social withdrawal, and reduced ability to perform basic and instrumental activities of daily living -typifies the older than 64 years in North Carolina. After controlling for age, cancer, and demographic factors, we found that blacks problems that patients, family, and clinicians face with any serious illness that affects the elderly [2] . The ultimate impact were four times less likely than whites (adjusted OR, 0.25; 95% CI, 0.18 -0.35; P Å .0001) to have had zoster in their of zoster in serious cases such as this one depends on the physiological reserve of the elderly patient. In the well elder, lifetime, and blacks were significantly less likely to develop incident cases of zoster in 6 years of follow-up (adjusted risk it profoundly lowers quality of life; in the frail elder, these changes can induce a downward spiral to loss of independence ratio [RR], 0.35; 95% CI, 0.24 -0.51; P õ .001) [9, 10]. The reasons for these significant racial differences remain unclear and life.
but may involve racial differences in onset of primary infection, in reexposure to VZV throughout life, or in immunity to VZV [11] .
Epidemiology
Malignancy is common in elderly persons and has an important relationship with zoster. Hodgkin's disease, non-HodgHerpes zoster is caused by the reactivation of varicella-zoster virus (VZV) from a latent state in dorsal sensory and cranial kin's lymphomas, and leukemias pose a high risk for zoster [12, 13] . Patients with solid tumors are at lesser risk for zoster, ganglia. VZV reactivation and the incidence of zoster increase so strikingly with age that the majority of zoster cases worldbut treated patients with lung, breast, or gynecologic cancers of any age were more likely to have zoster than patients with wide occur in the elderly [3] . Why are the elderly so vulnerable to developing zoster? The answer, in part, is thought to be other solid tumors in one study [13] . Conversely, zoster is not a risk factor for cancer, so the presence of zoster in an elderly immunosenescence. Cellular immune dysfunction is a very important risk factor for zoster, particularly in patients with patient should not by itself initiate a search for a presumed underlying malignancy [14] . hematologic malignancies, patients with AIDS, and patients receiving immunosuppressive therapies [4] . Furthermore, investigators have demonstrated a significant age-related decline Clinical Issues in the number and function of T cell responders to VZV. Miller first demonstrated that the proliferative response of these cells
The first symptom of zoster is usually pain or abnormal sensations in the affected dermatome before the rash appears. to VZV antigen in vitro was significantly less in the elderly [5] . Berger et al. confirmed age-related differences in VZV Without this diagnostic marker, elderly patients are often exposed to unrevealing diagnostic tests and a host of misdiagnoantigen -dependent lymphocyte proliferation by demonstrating a low or absent stimulation index in lymphocytes from 33 ses. One clue to incipient zoster before the rash appears is tender or sensitive skin in the affected dermatome. Zoster (33%) of 100 healthy elderly persons and 0 of 43 persons aged 20 -40 years [6] .
should be in the differential diagnosis of any acute, dermatomal pain syndrome in the elderly. Burke et al. studied lymphocyte proliferation and skin test reactivity to VZV antigen in 157 healthy, latently infected After days to weeks of this painful prodrome, the characteristic erythematous, maculopapular and then vesicular, dermatosubjects of all ages and found that mean stimulation indices declined significantly by decade and that the percentage of mal rash erupts, and zoster usually becomes easy to diagnose. The diagnosis should be made as early as possible because positive skin test responses to VZV progressively declined, from 89% of 30 -40-year-olds to 8% of 70 -80-year-olds [7] . antiviral therapy must be initiated within 72 hours of the onset of rash to enhance the likelihood of a successful outcome. Finally, Hayward and Herberger showed that the frequency of VZV-responsive lymphocytes (responder cell frequency; mean However, elderly patients may delay coming to the doctor because they underestimate the problem, fear the diagnosis or { SD) is significantly lower in the elderly (1/78,000 { 6,600) than in younger individuals (1/14,300 { 2,000) [8] . However, its consequences, do not appreciate the rash, are socially isolated, or avoid the health care system. This type of illness whether this apparent age-related decline is cause or coincidence has not been determined, since these cross-sectional studbehavior is common in elderly persons and is termed underreporting of symptoms in the geriatric literature [15] . Ageism Once it is diagnosed, elderly patients and family members healing in this trial, the median time to loss of pain was 63 days with famciclovir (500 mg three times a day) and 120 days may harbor significant concerns about the illness. One concern is that the patient will cause zoster or chickenpox in family or with placebo (P Å .02) [26] . Famciclovir has not been approved by the U.S. Food and Drug Administration for ophthalmic friends. The vesicles do contain cell-free virus, which can be transmitted to other individuals via direct contact or the airzoster or for the immunosuppressed host. Valacyclovir, which is used in a three-times-a-day dosing regiborne route. Uninfected individuals may develop varicella after exposure to a vesicular zoster rash, so individuals with no men, has better bioavailability and reduced the duration of zoster pain (in comparison to that with acyclovir) in a large randomized, history of chickenpox or known to be seronegative should avoid close contact with the individual until the rash has crusted over controlled trial in the elderly. The median time to loss of pain from zoster onset in this trial was 38 days for valacyclovir (1 g [16] . This recommendation is important in the nursing home or hospital, where caregivers are often women of child-bearing three times a day) and 51 days for standard doses of acyclovir [27] . It can be used in ophthalmic zoster but not in the immunoage. However, there is no convincing evidence that zoster patients cause zoster or chickenpox in latently infected seroposisuppressed host, on the basis of case reports of hemolytic-uremic syndrome in association with the drug. tive individuals, who constitute ú95% of the adult population.
Another obvious concern is PHN. The most common definiRemarkably, elderly patients tolerate these drugs very well, experiencing nausea, diarrhea, and headache 5% -15% of the tions of PHN are pain 1 or 3 months after the onset of the zoster rash or pain after the rash has healed. Regardless of time.
On the basis of current data, it is difficult to say whether one agent is clearly superior to the other or that they uniformly exact definition, PHN is highly age-related. For example, pain 1 month after rash onset occurred in 10% of untreated zoster prevent PHN. Unfortunately, treated patients may develop persistent zoster pain, possibly because several days of viral replipatients õ40 years old and 68% of those ú60 years old in one large study [17] . Furthermore, pain lasting ú1 year occurs cation and inflammation have taken place by the time the patient reaches the doctor. in õ5% of young individuals, whereas it occurs in up to 48% of persons ú70 years old [18] . Why are the elderly so vulneraCorticosteroid drugs, in many forms, have been used by clinicians for years in attempts to reduce the inflammation and ble to development of PHN? The answer to this question remains an enigma and another area in need of investigation [19, pain of zoster. However, doubts about corticosteroids have centered around ineffectiveness in preventing PHN, potential 20]. Other much less common but devastating complications of zoster in the elderly include loss of vision with ophthalmic dissemination of VZV, and adverse effects, particularly in the frail elderly. Three well-designed randomized, controlled trials zoster, facial or limb paresis, encephalitis, hepatitis, and pneumonitis.
in the past 10 years showed no significant differences in the incidence or duration of PHN in steroid-treated patients (compared with those in placebo or acyclovir recipients), with or Management without the concomitant use of acyclovir [24, 28, 29] . The median age of patients in these studies ranged from 60 to 65 The principal reason to treat elderly patients with zoster is the reduction or elimination of pain and disability. The optimal years, and they were excluded if they had diabetes mellitus, hypertension, osteoporosis, or cancer, which are common conmeasurement and analysis of pain in elderly patients and of the impact of zoster on health-related quality of life and funcditions in elderly patients. Their results argue against the routine use of corticosteroids in elderly patients with zoster. Howtional status have been subjects of considerable debate and require ongoing research [21, 22] . Nonetheless, pain has been ever, it should be noted that corticosteroids reduced acute pain in these studies. In addition, Whitley et al. found that the time the focus of recent clinical trials with three agents that have activity against VZV: acyclovir, famciclovir, and valacyclovir.
until uninterrupted sleep, return to usual activity, and reduction of analgesic use were achieved was significantly shorter in the All three drugs reduce acute pain and may reduce duration of chronic pain when used within 72 hours of the onset of rash corticosteroid-treated group [29] . Infection control in the nursing home or hospital is an im-[18]. Oral acyclovir (800 mg five times a day) also reduces ocular complications in ophthalmic zoster, and intravenous portant zoster-related issue. Seronegative nursing home and hospital staff should avoid contact with the zoster patient until acyclovir (10 mg/kg every 8 hours) is effective in treating visceral or CNS complications in the immunosuppressed host. the rash has crusted over, to avoid varicella. The U.S. Centers for Disease Control and Prevention recommend a private room Its disadvantages are poor oral bioavailability, a five-times-aday dosing schedule, and conflicting data regarding its effect and standard precautions for immunocompetent hospitalized patients with localized zoster, to protect susceptible staff memon PHN [18, 23 -25] .
Famciclovir has better bioavailability than acyclovir, is used bers and patients [16] . In addition to standard precautions, they recommend a private room with negative-pressure ventilation in a three-times-a-day dosing regimen, and significantly reduced the duration of zoster pain (compared to that with plaand airborne and contact precautions for immunocompromised patients with localized zoster or any patient with disseminated cebo) in a randomized, controlled trial that included elderly participants. In patients with PHN, as defined as pain at rash zoster. Similar measures are advocated for zoster patients in
